125 related articles for article (PubMed ID: 18282234)
61. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study.
Thariat J; Ahamad A; El-Naggar AK; Williams MD; Holsinger FC; Glisson BS; Allen PK; Morrison WH; Weber RS; Ang KK; Garden AS
Cancer; 2008 Jun; 112(12):2698-709. PubMed ID: 18429002
[TBL] [Abstract][Full Text] [Related]
62. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
63. IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts.
Marino M; Scuderi F; Provenzano C; Scheller J; Rose-John S; Bartoccioni E
J Neuroimmunol; 2008 May; 196(1-2):41-8. PubMed ID: 18400310
[TBL] [Abstract][Full Text] [Related]
64. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
[TBL] [Abstract][Full Text] [Related]
65. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
66. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
Lango MN; Andrews GA; Ahmad S; Feigenberg S; Tuluc M; Gaughan J; Ridge JA
Head Neck; 2009 Mar; 31(3):328-37. PubMed ID: 18853450
[TBL] [Abstract][Full Text] [Related]
67. Analysis of the horseradish peroxidase/indole-3-acetic acid combination in a three-dimensional tumor model.
Tupper J; Greco O; Tozer GM; Dachs GU
Cancer Gene Ther; 2004 Jul; 11(7):508-13. PubMed ID: 15143345
[TBL] [Abstract][Full Text] [Related]
68. Optimisation of Conditions for the Formation of Spheroids of Head and Neck Squamous Cell Carcinoma Cell Lines for Use as Animal Alternatives.
Tenschert E; Kern J; Affolter A; Rotter N; Lammert A
Altern Lab Anim; 2022 Nov; 50(6):414-422. PubMed ID: 36263982
[TBL] [Abstract][Full Text] [Related]
69. Immunosuppression Impact on Head and Neck Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-analysis.
Elghouche AN; Pflum ZE; Schmalbach CE
Otolaryngol Head Neck Surg; 2019 Mar; 160(3):439-446. PubMed ID: 30348055
[TBL] [Abstract][Full Text] [Related]
70. Recent advances in Oral Oncology 2007: epidemiology, aetiopathogenesis, diagnosis and prognostication.
Bagan JV; Scully C
Oral Oncol; 2008 Feb; 44(2):103-8. PubMed ID: 18252251
[TBL] [Abstract][Full Text] [Related]
71. Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma.
Hagemann J; Jacobi C; Gstoettner S; Welz C; Schwenk-Zieger S; Stauber R; Strieth S; Kuenzel J; Baumeister P; Becker S
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29733308
[TBL] [Abstract][Full Text] [Related]
72. Evolution of the brain tumour spheroid model: transcending current model limitations.
Corcoran A; De Ridder LI; Del Duca D; Kalala OJ; Lah T; Pilkington GJ; Del Maestro RF
Acta Neurochir (Wien); 2003 Sep; 145(9):819-24. PubMed ID: 14505114
[TBL] [Abstract][Full Text] [Related]
73. Spheroid-based 3D Cell Cultures Enable Personalized Therapy Testing and Drug Discovery in Head and Neck Cancer.
Hagemann J; Jacobi C; Hahn M; Schmid V; Welz C; Schwenk-Zieger S; Stauber R; Baumeister P; Becker S
Anticancer Res; 2017 May; 37(5):2201-2210. PubMed ID: 28476783
[TBL] [Abstract][Full Text] [Related]
74. Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones.
Tas MP; Simons PJ; Balm FJ; Drexhage HA
Cancer Immunol Immunother; 1993; 36(2):108-14. PubMed ID: 8425208
[TBL] [Abstract][Full Text] [Related]
75. An autologous system for culturing head and neck squamous cell carcinomas for the assessment of cellular therapies on the chorioallantois membrane.
Gronau S; Thess B; Riechelmann H; Fischer Y; Schmitt A; Schmitt M
Eur Arch Otorhinolaryngol; 2006 Apr; 263(4):308-12. PubMed ID: 16252122
[TBL] [Abstract][Full Text] [Related]
76. Analysis of cellular composition of co-culture spheroids.
Dorst N; Oberringer M; Grässer U; Pohlemann T; Metzger W
Ann Anat; 2014 Sep; 196(5):303-11. PubMed ID: 24962944
[TBL] [Abstract][Full Text] [Related]
77. Elevated cytostatic activity of monocytes from cancer patients.
Mashiba H; Matsunaga K; Yagawa K; Nomura Y; Yoshinaga H; Furusawa M; Jimi S
Gan; 1981 Dec; 72(6):848-53. PubMed ID: 7341334
[TBL] [Abstract][Full Text] [Related]
78. Mononuclear phagocyte function in head and neck cancer: NBT-dye reduction, maturation and migration of peripheral blood monocytes.
Balm FJ; Drexhage HA; von Blomberg ME; Snow GB
Laryngoscope; 1982 Jul; 92(7 Pt 1):810-4. PubMed ID: 7087651
[TBL] [Abstract][Full Text] [Related]
79. In vitro monocyte maturation in squamous carcinoma of the lung.
Dent RG; Cole P
Br J Cancer; 1981 Apr; 43(4):486-95. PubMed ID: 7236490
[TBL] [Abstract][Full Text] [Related]
80. Immunosuppressive retroviral P15E-related factors in head and neck carcinomas.
Tan IB; Drexhage HA; Scheper RJ; von Blomberg-van de Flier BM; de Haan-Meulman M; Snow GB; Balm FJ
Arch Otolaryngol Head Neck Surg; 1986 Sep; 112(9):942-5. PubMed ID: 3741659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
